Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeFUNDINGNovo Holdings A/S Invests in Availity - A US Healthcare IT Company

Novo Holdings A/S Invests in Availity – A US Healthcare IT Company

Novo Holdings A/S (“Novo Holdings” and “NH”), a leading international investor in healthcare and life sciences, today announced a strategic minority investment in Availity, one of the largest healthcare data and administrative networks connecting payers and providers throughout the United States.

Availity is a leader in payer-provider collaboration. Through its digital provider engagement, clearinghouse, and revenue cycle technology solutions, Availity provides a critical infrastructure that connects hospitals and physicians with health plans while removing administrative burden and cost from the healthcare system. The company’s service offerings allow healthcare professionals to manage the administrative, clinical, and financial data needed to fuel real-time coordination among providers, health plans, and their patients, thereby increasing efficiency in the delivery of healthcare.

Availity connects over two million providers to every health plan in the United States. Through their multi-payer platform, Availity facilitates over 13 billion electronic transactions annually.

Availity was founded in 2001 and is headquartered in Jacksonville, Florida, with offices in Indianapolis, Indiana and Bangalore, India. The company employs 1,300 associates.

“We are delighted to welcome Novo Holdings as our newest partner,” said Russ Thomas, CEO, Availity. “Novo Holdings brings new and exciting perspectives to our organization. Their deep experience in global healthcare and commitment to build a stronger, more sustainable healthcare system will help us take payer-provider collaboration, and the tangible benefits of that collaboration, to the next level.”

“Novo Holdings will join our existing base of strategic shareholders who include Anthem, Inc., Humana, Health Care Service Corporation, and GuideWell,” said Thomas.

Novo Holdings is a leading healthcare and life sciences investor with a focus on creating long-term, sustainable value. Headquartered in Copenhagen, with offices in San Francisco, Boston, London and Singapore, Novo Holdings has a portfolio of more than 120 healthcare and life sciences companies and total assets of more than EUR 60 billion at the end of 2020. Healthcare IT is a strategic focus area for Novo Holdings, and Availity represents a strategic platform investment where Novo Holdings is eager to deploy more capital. Availity is Novo Holdings’ largest investment into healthcare IT to date.

“We are looking forward to becoming a strategic partner to Availity and joining the board. Healthcare IT and tech-enabled healthcare services are areas where we have robust experience and a strong network. As a long-term investor in healthcare and life sciences, we believe we can contribute valuable knowledge and perspectives to the company,” said Abhijeet Lele, Senior Partner and Head of U.S. Principal Investments, Novo Holdings A/S.

“We are excited to invest in a company at the center of the US healthcare system. Given the focus of Availity’s solutions on reducing administrative burden and wasteful spending, we see the company as having a positive societal benefit. We are looking forward to being part of Availity’s future growth trajectory and becoming part of a company whose services and innovations have such an important purpose in in the broader healthcare ecosystem,” said Jonathan Levy, Senior Partner, Principal Investments, Novo Holdings A/S.

Abhijeet Lele and Jonathan Levy will join the board of directors at Availity.

“The partnership with Novo Holdings reflects an important milestone in the growth of Availity. Novo Holdings brings a unique perspective and approach to the organization and a broad view of ways to positively impact health care,” said Chuck Divita, Board Chair of Availity and GuideWell’s Executive Vice President of Commercial Markets. “We welcome Abhijeet and Jonathan to the Board and look forward to advancing Availity with Novo Holdings.”

Novo Holdings acquired its stake in Availity from Francisco Partners, a global investment firm that specializes in partnering with technology businesses, which had been an investor in Availity since 2017.

Goldman Sachs & Co. LLC acted as an exclusive financial advisor, and Davis Polk & Wardwell LLP and Taft Stettinius & Hollister LLP acted as legal advisors to Availity, LLC. Goodwin Proctor LLP acted as legal advisor to Novo Holdings.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy